RIYADH: Saudi Arabia has launched a genetic code mapping project aimed at identifying the basis of chronic diseases prevalent in the desert kingdom.
The Saudi Human Genome Program will be run by Saudi researchers, in cooperation with the U.S. Life Technologies Corp., at the King Abdul-Aziz City for Science and Technology.
“The program aims to identify the causes of prevalent chronic diseases in Saudi Arabia,” Prince Moqrin bin Abdul-Aziz, the second deputy prime minister, said Sunday.
The program will work over five years on sequencing 100,000 human genomes to study both normal and disease-associated genes specific to the Saudi population, a statement from Life Technologies said.
“This genomic variant data will be fully analyzed and used to create a Saudi-specific database that will provide the basis for future development of personalized medicine in the kingdom,” it said.
The sequencing will be performed using Life Technologies’ semiconductor-based Ion Proton DNA sequencer, it added. The instruments will be deployed at 15 genome centers across the kingdom, it said.
“We believe the Saudi Human Genome Program will help shape the understanding of health and disease and usher in an era of personalized medicine in the Kingdom of Saudi Arabia,” KACST President Mohammad al-Suwayl said.
KACST and China’s Shenzhen-based BGI succeeded in 2010 in decoding the entire genetic makeup of the single-humped camel, the omnipresent dromedary native to the Arabian Peninsula.
Unlocking the genetics underpinning the camel’s immune system could lead to potential medical discoveries, and the genome data can also help scientists understand better how the mammal produces its highly nutritious and medically valuable milk.